Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Posts Tagged: Israel

Country count for new FCPA investigations

Since the start of 2018, companies and agencies have disclosed 19 new FCPA-related investigations.

Of the newly disclosed investigations, five have been closed, either by enforcement actions or declinations.

Fourteen of the new investigations remain open and apparently active.… Continue Reading

Israel arms exports will require KYC and sanctions checks

The agency in charge of granting licenses to defense exporters will start to require KYC, blacklist, and sanctions searches to applications for marketing and export licenses. This move is meant to strengthen control by Israeli authorities over marketing and export of military goods, which sometimes allegedly find their way into dubious hands.… Continue Reading

Israel imposes strict compliance regs on pharmas, medical device makers

Any company marketing medicine or equipment to the Israeli healthcare system (hospitals and health patient funds) needs to meet new compliance-related regulations by setting internal procedures, training employees and third parties, and improving the allocation of marketing and R&D resources when carrying out business in Israel.   … Continue Reading

SEC charges Israeli company with FCPA offenses

Elbit Imaging LTD. agreed Friday to pay $500,000 to settle violations of the FCPA books and records and the internal controls provisions.

Israel-based Elbit and its subsidiary, Plaza Centers NV, paid millions of dollars to third-party offshore consultants and a sales agent “for services,” without knowing if the services were ever provided.… Continue Reading

Teva announces $519 million FCPA settlement

Teva Pharmaceuticals Industries Ltd. agreed Thursday with the DOJ and SEC to resolve FCPA violations through a deferred prosecution agreement and total payments of $519 million.

The $519 million settlement will rank fourth on our list of the ten biggest FCPA cases.… Continue Reading